It has been also reported that the expression of BRAF V600E mutation and the RET/PTC gene rearrangement promote the activity of NF-kB, the expression of inflammatory mediators, and lymph node metastases in patients with papillary thyroid cancer (PTC) (129). Here, RET is linked to thyroid gland papillary carcinoma.